- Home
- NVCT vs ALEC Comparison
NVCT vs ALEC Comparison
Compare NVCT & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCT
- ALEC
- Stock Information
- Founded
- NVCT 2020
- ALEC 2013
- Country
- NVCT United States
- ALEC United States
- Employees
- NVCT N/A
- ALEC N/A
- Industry
- NVCT Medicinal Chemicals and Botanical Products
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NVCT Health Care
- ALEC Health Care
- Exchange
- NVCT Nasdaq
- ALEC Nasdaq
- Market Cap
- NVCT 152.3M
- ALEC 124.0M
- IPO Year
- NVCT 2022
- ALEC 2019
- Fundamental
- Price
- NVCT $6.43
- ALEC $2.25
- Analyst Decision
- NVCT Strong Buy
- ALEC Buy
- Analyst Count
- NVCT 3
- ALEC 8
- Target Price
- NVCT $15.33
- ALEC $4.50
- AVG Volume (30 Days)
- NVCT 234.7K
- ALEC 1.4M
- Earning Date
- NVCT 08-05-2025
- ALEC 08-07-2025
- Dividend Yield
- NVCT N/A
- ALEC N/A
- EPS Growth
- NVCT N/A
- ALEC N/A
- EPS
- NVCT N/A
- ALEC N/A
- Revenue
- NVCT N/A
- ALEC $81,130,000.00
- Revenue This Year
- NVCT N/A
- ALEC N/A
- Revenue Next Year
- NVCT N/A
- ALEC $319.82
- P/E Ratio
- NVCT N/A
- ALEC N/A
- Revenue Growth
- NVCT N/A
- ALEC 46.77
- 52 Week Low
- NVCT $4.44
- ALEC $0.87
- 52 Week High
- NVCT $11.80
- ALEC $6.37
- Technical
- Relative Strength Index (RSI)
- NVCT 39.18
- ALEC 62.73
- Support Level
- NVCT $6.18
- ALEC $1.99
- Resistance Level
- NVCT $6.99
- ALEC $2.50
- Average True Range (ATR)
- NVCT 0.50
- ALEC 0.22
- MACD
- NVCT -0.03
- ALEC 0.07
- Stochastic Oscillator
- NVCT 31.18
- ALEC 76.85
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.